QIAGEN - Cellestis GmbHChief Commercial Officer Cellestis Group
Jan. 2005 - Feb. 2012Darmstadt, GermanyEMEA-wide sales, marketing and regulatory success based on the replacement of the world's oldest immunological test with a novel, disruptive technology. Company sold to QIAGEN in August 2011 for $400 million. Major contributions to the company's success: Full-coverage market penetration strategy, team and infrastructure build, drive for establishment of published medical evidence base, sustained growth in sales, profit and contribution margins.